The US Genome Sequencing Market Analysis, 2020

marknteladvisors.com

The US Genome Sequencing Market Analysis, 2020

Document Outline

Introduction About Us, Key Questions Answered In This Study

Table of Content Market Segmentation, Scope of Work

Research Process & Methodology Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research Methodology, Forecasting

Sample Pages The US Genome Sequencing Market Analysis, 2020

02

05

11

19

Commercials

42

Disclaimer

44

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

2

Market Segmentation The US Genome Sequencing Market Segmentation

By Application

By End User

• Biomarker & Cancer

• Hospitals & Clinics

• Personalized medicine

• Academic & Government

• Forensic • Reproductive Health

Research Institute • Biotechnology &

• Diagnostics

Pharmaceutical

• Others

Companies

By Region

• South • West

By Technology

By Company

• Sequencing By Synthesis

• Abbott

• Ion Semiconductor

• Roche

Sequencing

• Agilent

• Midwest

• Pyrosequencing

• PerkinElmer

• Northeast

• Sequencing By Ligation

• Siemens

• Chain Termination

• Illumina

By Product

Technology • Single-Molecule Real-

• Consumables

• Instruments • Services

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

Time Sequencing

• Nanopore Sequencing • Others

• ThermoFisher • Pacific Biosciences • Integrated DNA

Technologies • Cytiva

3

Historical Year: 2015 Base Year: 2019

Table of Content (1/4)

Forecast Year: 2025 Table of Content

1.

Introduction

1.1.

Product Definition

1.2.

Research Process

1.3.

Market Segmentation

1.4.

Assumptions

2.

Executive Summary

3.

The US Genome Sequencing Market Start-Up Ecosystem

4.

Impact of COVID-19 on The US Genome Sequencing Market

5.

Expert Verbatim-Interview Excerpts of industry experts

6.

The US Genome Sequencing Market Outlook, 2015-2025F 6.1.

Market Size & Analysis 6.1.1. Revenues

6.2.

Market Share & Analysis 6.2.1. By Product 6.2.1.1. Consumables 6.2.1.2. Instruments 6.2.1.3. Services

6.2.2. By Technology 6.2.2.1. Sequencing By Synthesis 6.2.2.2. Ion Semiconductor Sequencing Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

4

Historical Year: 2015 Base Year: 2019

Table of Content (2/4)

Forecast Year: 2025 Table of Content

6.2.2.3. Pyrosequencing

6.2.2.4. Sequencing By Ligation 6.2.2.5. Chain Termination Technology 6.2.2.6. Single-Molecule Real-Time Sequencing 6.2.2.7. Nanopore Sequencing 6.2.2.8. Others 6.2.3. By Application 6.2.3.1. Biomarker & Cancer 6.2.3.2. Personalized medicine 6.2.3.3. Forensic 6.2.3.4. Reproductive Health 6.2.3.5. Diagnostics

6.2.3.6. Others 6.2.4. By End User 6.2.4.1. Hospitals & Clinics 6.2.4.2. Academic & government research institute 6.2.4.3. Biotechnology & Pharmaceutical Companies

6.2.5. By Region 6.2.5.1. South 6.2.5.2. West Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

5

Historical Year: 2015 Base Year: 2019

Table of Content (3/4)

Forecast Year: 2025 Table of Content

6.2.5.3. Midwest

6.2.5.4. Northeast 6.2.6. By Company 6.2.6.1. Market Shares, By Revenue 6.2.6.2. Strategic Factorial Indexing 6.2.6.3. Competitor Placement in MarkNtel Quadrant 6.3.

Market Attractiveness Index 6.3.1. By Product 6.3.2. By Technology 6.3.3. By Application 6.3.4. By End User 6.3.5. By Region

7.

The US Genome Sequencing Market Policies, Regulations, Product Standards

8.

The US Genome Sequencing Market Trends & Insights

9.

The US Genome Sequencing Market Dynamics 9.1.

Growth Drivers

9.2.

Challenges

9.3.

Impact Analysis

10. The US Genome Sequencing Market Hotspot & Opportunities 11. The US Genome Sequencing Market Key Strategic Imperatives for Success & Growth Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

6

Historical Year: 2015 Base Year: 2019

Table of Content (4/4)

Forecast Year: 2025 Table of Content

12. Competition Outlook 12.1. Competition Matrix 12.1.1. Product Portfolio

12.1.2. Target Markets 12.1.3. Target End User 12.1.4. Research & Development 12.1.5. Strategic Alliances 12.1.6. Strategic Initiatives

12.2. Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans) 12.2.1. Abbott

12.2.2. Roche 12.2.3. Agilent 12.2.4. PerkinElmer 12.2.5. Siemens 12.2.6. Illumina

12.2.7. ThermoFisher 12.2.8. Pacific Biosciences 12.2.9. Integrated DNA Technologies 12.2.10. Cytiva 13. Disclaimer Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

7

Document Outline

Introduction About Us, Key Questions Answered In This Study

Table of Content Market Segmentation, Scope Of Work

Research Process & Methodology Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research Methodology, Forecasting

Sample Pages The US Genome Sequencing Market Analysis, 2020

02

05

11

19

Commercials

42

Disclaimer

44

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

8

The US Genome Sequencing Market Outlook, 2015-2025F

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

The US Genome Sequencing Market Outlook, By Revenues Figure XX: The US Genome Sequencing Market Revenues (USD Million), 2015 - 2025F

2015

2016

2017

Revenue: XX%

CAGR

CAGR

Revenue: XX%

2018

2019

2020E

2021F

2022F

2023F

2024F

2025F

Source: MarkNtel Advisors

• The US genome sequencing market is burgeoning over the past few years due to advancements in genome sequencing technology. NextGeneration Sequencing (NGS) is enabling research organizations to determine unknown pathogens that have not been identified by conventional methods, therefore this technology is widely used in forensic biology, diagnostic, etc. The increasing number of applications of next-generation sequencing has been contributed to the growth of the US market. Growing obesity, work life, declining physical activity,

etc., in the US are few of the factors which are contributing immensely to the growth of cancer patients. The US ranks among the leading countries with higher percentage of obese population in 2019. • The outbreak of COVID-19 has generated the requirement for vaccines for the treatment of coronavirus. The number of companies and Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

10

The US Genome Sequencing Market Revenue Share, By Product Figure XX: The US Genome Sequencing Market Revenue Share (%), By Product, 2015 - 2025F

2015

2016

2017

2018

2019 Consumables

2020 Instruments

2021

2022

2023

2024

2025

Services

*These are dummy charts and do not represent actual value

Source: MarkNtel Advisors

• Consumables: The presence of large healthcare companies coupled with the mounting research and development to develop novel drugs in the country is expected to augment the demand for consumables during the forecast years 2020-25. Moreover, the rising number of

healthcare startups has been propelling the research and development in the US, which in turn proliferate the demand for consumables. • The risk of developing several diseases such as cardiovascular, and infectious disease, etc. is high in the aging population and all the medicines are not equally beneficial for the treatment of elder patients. Therefore, genome sequencing is used in hospitals to provide precise treatment to aged patients. In 2019, there were around 53 million individuals aged 65 or above which are anticipated to reach about 70 million by 2030. With the growing number of elder individuals in the country, the demand for consumables is supposed to surge

by 2025.

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

11

The US Genome Sequencing Market Revenue Share, By Technology Figure XX: The US Genome Sequencing Market Revenue Share (%), By Technology, 2019 & 2025F • Nanopore Sequencing: The demand

technology

for

is

• The foodborne disease is a

Sequencing By Synthesis

nanopore

generating Others

due to its portable and cost-

2019

2025

XX%

XX%

cause

of

death

in

the

country. Around 48 million

Ion Semiconductor Sequencing

individuals get sick every

effective properties amid

2019

2025

2019

2025

year in the US as reported

end-users in the US.

XX%

XX%

XX%

XX%

by the Centers for Disease

• Moreover, the capability of nanopore

technology

Control & Prevention. The

to

analyze a large number of genome sequencing at a

faster speed also surging the demand for nanopore

research agencies' focus to Nanopore Sequencing 2019

2025

XX%

XX%

Pyrosequencing

2019: USD XX Million

2019

2025

XX%

XX%

technology in the country.

However, a high error rate through the utilization of nanopore genome

technology

determine the foodborne pathogens in the country is expected

to

demand

for

drive

the

nanopore

technology by 2025.

SingleMolecule Real-Time Sequencing

in

2019

2025

sequencing

XX%

XX%

Sequencing

By Ligation Chain Termination Technology

comparison to alternatives

2019

2025

has been hampering the

XX%

XX%

growth of the segment.

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

2019

2025

XX%

XX%

Source: MarkNtel Advisors

12

The US Genome Sequencing Market Revenue Share, By Application Figure XX: The US Genome Sequencing Market Revenue Share (%), By Application, 2019 & 2025F

Biomarker & Cancer Personalized medicine

2019

Forensic

2025F

Reproductive Health Diagnostics Others

*These are dummy charts and do not represent actual value

Source: MarkNtel Advisors

• Biomarker & Cancer: This is among the major applications supporting the US market over the past few years. Genome sequencing is used to determine the cause of cancer in each patient which assists the healthcare specialists to provide effective treatment. Around 1.8 million individuals are expected to be diagnosed in the US in 2020 as reported by the American Cancer Society. With the surging number of cancer patients in the country, the demand for genome sequencing is anticipated to augment by 2025.

• The increasing adoption of advanced technologies, good quality treatment in the hospitals, and surging disposable income are among the key factors that attract patients to visit the US from the other countries for the treatment of cancer since 2015. This is expected to increase medical tourism in the United States by 2025 and subsequently drive the demand for genome sequencing in hospitals and cancer specialty

centers. Thus, expected that the market share or the investments in biomarker and cancer segment would augment by 2025.

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

13

The US Genome Sequencing Market Size, By End User Figure XX: The US Genome Sequencing Market Size (USD Million), By End User, 2019 & 2025F

2019 Biotechnology & Pharmaceutical Companies

2025F

Biotechnology & Pharmaceutical Companies

Academic & Government Research Institute

Academic & Government Research Institute

Hospitals & Clinics

Hospitals & Clinics *These are dummy charts and do not represent actual value

Source: MarkNtel Advisors

• Academic & Government Research Institute: These institutes are among the major end-users of genome sequencing in the United States and the growth of the segment supported by an increasing number of investments from the government & private institutes. For instance: The US National Institutes of Health (NIH) announced a plan to award USD 7 million to HudsonAlpha Institute to increase the US health

dataset with undiscovered genetic variations in October 2019. This is expected to generate the demand for whole genome sequencing technology. • The government initiatives further support the segment to grow over the past few years. For instance: Precision Medicine Initiative named All of Us Research Program of National Institutes of Health has been introduced in 2016, the project comprises clinical sequencing to expand the reach of precision medicine for the treatment of all diseases in the country.

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

14

The US Genome Sequencing Market Revenue Share, By Region Figure XX: The US Genome Sequencing Market Revenue Share (%), By Region, 2019 & 2025F

2019: X% 2019: X%

2025F: X%

2025F: X% 2019: X%

Northeast

2025F: X%

West

Midwest

South 2019: X% 2025F: X%

Source: MarkNtel Advisors

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

15

The US Genome Sequencing Market Dynamics  Drivers  Challenges

 Impact Analysis

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

Impact Analysis- Drivers & Challenges Short Term (2020-2021)

Mid Term (2022-2025)

Long Term (2026- 2030)

Drivers

The government initiatives coupled with increasing investment in research and development are driving the demand for genome sequencing

XXXXXXXXXXXX

XXXXXXXXXXX

Challenges

XXXXXXXXXXX

XXXXXXXXX

Intensity of Increasing Growth Prospects Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

17

+1 (613) 707-5086 sales@marknteladvisors.com

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

18